News, Analysis & Insights on Nutrition, Supplements, and Health
New Zealand's food processors are set to invest more in convenient and healthier foods as healthy eating and a balanced diet is becoming a high priority for most people – particularly in households with children.
Two companies have pleaded guilty to unlawful manufacture and distribution in interstate commerce of drugs misbranded as dietary supplements, following an investigation by the FDA.
The number of new products launched in the US market featuring the term ‘diet’ in the brand or product name has plummeted in the last five years as weight conscious shoppers seek out more positive messages, according to market researchers.
EFSA has approached an expert who has already worked with its health claims panel to make a report on the characterisation of probiotic strains – an issue that led to the rejection of 260 out of 300 probiotic health claim dossiers - and most of which are...
In a bid to tackle malnutrition in India, global health care company Abbott has teamed up with not-for-profit group, Path, to advance the development of nutrition-enriched rice in the Indian market.
POM Wonderful has branched out into the ingredients supply market with plans to launch its POMx pomegranate polyphenols as a functional ingredient for other manufacturers to use on a global basis.
UK whey supplier Volac is making a push at the nutrition bar market with its whey offerings – especially that segment of the market concerned with weight management.
Daily doses of vitamin E may improve memory associated with a lack of sleep, suggests new data from rats.
CLA consumption may raise cholesterol and insulin levels, the French food agency has found after assessing recent in vitro and animal studies.
A proposed change to the date defining ‘grandfathered’ dietary ingredients to 2007 shows the industry there are options to the NDI issue, but it should not distract attention from FDA and the upcoming deadline for NDI comment submissions, say leading...
Heart healthy food giants Raisio and Unilever have clashed over proposed changes to the wording of health claims about phytosterols and the risk of coronary heart disease.